• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

10 months ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

AAVE Approaches Key Weekly Support Level

chest

AAVE is approaching the key weekly support level of 150, which may influence future price movements and market sentiment.

user avatarLuis Flores

Increased Risks for Crypto Investors on Black Friday

chest

Black Friday presents higher risks for crypto investors due to increased scams and phishing attempts. Investors are advised to be vigilant and follow safety measures.

user avatarArif Mukhtar

CryptoAppsy Launches to Simplify Cryptocurrency Tracking

chest

CryptoAppsy has launched a cryptocurrency tracking app that provides real-time data without registration, enhancing user experience and investment management.

user avatarMaria Gutierrez

User Feedback Highlights CryptoAppsy's Value

chest

User feedback highlights the value of CryptoAppsy, which has received positive ratings for its functionality and ease of use.

user avatarJacob Williams

Avicenne Launches Groundbreaking Bridge Between Qubic and Solana

chest

Avicenne has developed a novel crosschain infrastructure connecting Qubic and Solana, enhancing blockchain interoperability and access to liquidity.

user avatarDavid Robinson

CryptoAppsy Launches to Assist Cryptocurrency Investors

chest

CryptoAppsy is a new application designed to assist cryptocurrency investors with real-time data and portfolio management.

user avatarAndrew Smith

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.